دورية أكاديمية

A Randomized Comparison of Artesunate-Atovaquone- Proguanil versus Quinine in Treatment for Uncomplicated Falciparum Malaria during Pregnancy.

التفاصيل البيبلوغرافية
العنوان: A Randomized Comparison of Artesunate-Atovaquone- Proguanil versus Quinine in Treatment for Uncomplicated Falciparum Malaria during Pregnancy.
المؤلفون: McGready, Rose, Ashley, Elizabeth A., Eh Moo, Them Cho, Barends, Marion, Hutagalung, Robert, Looareesuwan, Sornchai, White, Nicholas J., Nosten, François
المصدر: Journal of Infectious Diseases; 9/1/2005, Vol. 192 Issue 5, p846-853, 8p
مصطلحات موضوعية: PLASMODIUM falciparum, MALARIA, FEVER, PROTOZOAN diseases, PREGNANT women, PREGNANCY
مستخلص: Background. There is no safe, practical, and effective treatment for pregnant women infected with multidrug-resistant Plasmodium falciparum. Methods. We recruited pregnant Karen women in the second or third trimesters of pregnancy who had uncomplicated falciparum malaria for a randomized, open-label trial with a restricted sequential trial design of 7 days of supervised quinine (SQ7) versus 3 days of artesunate-atovaquone-proguanil (AAP). Results. Eight-one pregnant women entered the study between December 2001 and July 2003; 42 were treated with SQ7 and 39 were treated with AAP. Fever, parasite clearance, and duration of anemia were significantly better with AAP; the treatment failure rate was 7 times lower (5% [2/39] vs. 37% [15/41]; relative risk, 7.1 [95% confidence interval, 1.7–29.2]; P = .001). There were no significant differences in birth weight, duration of gestation, or congenital abnormality rates in newborns or in growth and developmental parameters of infants monitored for 1 year. Conclusion. AAP is a well-tolerated, effective, practical, but expensive treatment for multidrug-resistant falciparum malaria during the second or third trimesters of pregnancy. Despite the small number of subjects, our results add to the growing body of evidence that AAP is safe for the mother and the fetus. [ABSTRACT FROM AUTHOR]
Copyright of Journal of Infectious Diseases is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:00221899
DOI:10.1086/432551